885269-66-9 Usage
Uses
Used in Pharmaceutical Industry:
6-Methyl-1H-pyrazolo[3,4-b]pyridine is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and properties make it a valuable component in the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 6-Methyl-1H-pyrazolo[3,4-b]pyridine serves as a crucial building block for the creation of novel agrochemicals. Its incorporation into these compounds can lead to the development of more effective and targeted pesticides, herbicides, and other agricultural products.
Used in Materials Science:
6-Methyl-1H-pyrazolo[3,4-b]pyridine is utilized as a component in the development of advanced materials with specific properties. Its incorporation into materials can enhance their performance, making them suitable for various applications, such as in electronics, sensors, or other high-tech industries.
Used as a Building Block in Organic Synthesis:
6-Methyl-1H-pyrazolo[3,4-b]pyridine is employed as a versatile building block in organic synthesis, allowing chemists to create a wide range of chemical compounds with diverse applications. Its unique structure and reactivity make it an essential component in the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 885269-66-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,6 and 9 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 885269-66:
(8*8)+(7*8)+(6*5)+(5*2)+(4*6)+(3*9)+(2*6)+(1*6)=229
229 % 10 = 9
So 885269-66-9 is a valid CAS Registry Number.
885269-66-9Relevant academic research and scientific papers
KINASE INHIBITOR
-
, (2017/06/21)
[Problem] To provide a novel PIM-3 inhibitor and a novel cancer therapeutic drug, in particular, a therapeutic drug for pancreatic cancer. [Solution] A PIM-3 kinase inhibitor comprising a compound represented by general formula (I) or a pharmacologically acceptable salt, hydrate or solvate thereof.
NOVEL RENIN INHIBITOR
-
Paragraph 0403; 0404, (2015/09/22)
The present invention provides a nitrogen-containing saturated heterocyclic compound of the formula [I] which is useful as a renin inhibitor. wherein R1 is a cycloalkyl group or an alkyl, R22 is an optionally substituted aryl and the like, R is a lower alkyl group, R3, R4, R5 and R6 are the same or different, and are a hydrogen atom, an optionally substituted carbamoyl, an optionally substituted alkyl, or alkoxycarbonyl, or a pharmaceutically acceptable salt thereof.
PYRROLOPYRAZINE KINASE INHIBITORS
-
, (2013/03/28)
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
